Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialEurope PMCOpen access

Effectiveness of combined regenerative medicine and exercise therapy for patients with knee osteoarthritis: a scoping review

Oka T., Suzuki K., Tanaka K., Okuyama K., Kitagawa T.

Randomized Controlled Trial on Knee Osteoarthritis, Osteoarthritis, published in Front Rehabil Sci (2025) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
Front Rehabil Sci (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40765719
PMCID
PMC12321541
DOI
10.3389/fresc.2025.1612615
Citations
1

Abstract (original English)

Background Regenerative therapies such as platelet-rich plasma (PRP) and stem cell treatments show promise for symptom relief in knee osteoarthritis (OA), but individual responses vary. Exercise therapy is a well-established intervention that enhances muscle strength and joint stability. Although both approaches are effective, their combined use remains underexplored. Notably, no systematic or scoping review has yet examined the specific types of regenerative medicine and exercise therapy used in combination, the outcome domains assessed (pain, function, structure, and quality of life), or the key evidence gaps. This scoping review aimed to examine these combinations, outcome domains, and gaps in the current evidence base. Methods A literature search was conducted in MEDLINE, CENTRAL, and CINAHL using keywords including "knee osteoarthritis," "regenerative medicine," and "exercise therapy." Studies were included if they compared regenerative medicine alone to regenerative medicine combined with exercise therapy. Two reviewers independently extracted data on pain, physical function, and patient-reported outcomes across short-term (6-24 weeks) and long-term (up to 96 weeks) follow-up. Results Three studies [two randomized controlled trials (RCTs), one non-RCT] were included. Sample sizes ranged from 17 to 32. Despite variations in PRP type (pure vs. leukocyte rich), and exercise

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research